Clash over stem cell patents in Europe
Opponents of biotech research have focused on ethical provisions in European law to challenge controversial patents. Eklavya Gupte reports on two pending cases at the EPO that may clarify some key questions
Many members of the public have ethical concerns about
cutting-edge technologies, and in no area is this more true
than life sciences. Questions such as who decides what research
should be allowed, what limits should be placed on experiments
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.